Sign In
Buy DXCM
$68.92
-0.150 (-0.217%)
At Close: Jun 23, 2026
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
08:45am, Saturday, 20'th Jun 2026
The GLP-1 revolution is quietly continuing even as investor interest has moved on to more timely topics. One of the best ways to access the fast-growing weight loss drug space is via makers like Novo
Living Longer Is Big Business. These Stocks Will Benefit.
02:14pm, Thursday, 18'th Jun 2026
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.
3 Stocks Doing the Heavy Lifting in Healthcare's Rebound
09:31am, Thursday, 18'th Jun 2026
Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks ha
The Healthcare M&A Wave
12:30pm, Wednesday, 17'th Jun 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
DXCM Receives FDA Clearance for Stelo OTC CGM System for Children
10:56am, Tuesday, 16'th Jun 2026
DexCom's FDA-cleared Stelo OTC glucose biosensor now covers children aged above 2 years not using insulin, expanding access to smartphone-linked CGM insights.
Here's Why DexCom (DXCM) is a Strong Growth Stock
10:46am, Tuesday, 16'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FDA clears first over-the-counter glucose monitor for children
04:15pm, Friday, 12'th Jun 2026
The U.S. Food and Drug Administration said on Friday it has expanded the use of Dexcom's Stelo Glucose Biosensor System to children with diabetes, making it the first over-the-counter continuous
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
06:08am, Thursday, 11'th Jun 2026
Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose sensors it bought from licensed distributors had been slated for destruction, after the device maker warned some units were
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
10:51am, Wednesday, 10'th Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes
02:31pm, Monday, 08'th Jun 2026
DXCM reports positive CONNECT trial results as Dexcom G7 improves HbA1c and time in range in adults with Type 2 diabetes not using insulin.
Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes
02:15pm, Monday, 08'th Jun 2026
DexCom Inc. (NASDAQ:DXCM) stock is trading higher on Monday after the diabetes management company reported positive results from its CONNECT randomized controlled trial.
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
03:00pm, Saturday, 06'th Jun 2026
[url="]DexCom, Inc.[/url] (NASDAQ: DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clini
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study
02:49pm, Saturday, 06'th Jun 2026
Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with routine care, a
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
02:45pm, Saturday, 06'th Jun 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically si
Skip the Oura Ring IPO. Buy These 10 Stocks Instead.
12:00am, Friday, 05'th Jun 2026
Oura Ring's IPO looks like Peloton in 2020 - great product, dangerous price. Ten public wellness stocks own the real trade.
